141 related articles for article (PubMed ID: 26626190)
21. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.
Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA
Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554
[TBL] [Abstract][Full Text] [Related]
22. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
23. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis.
Zhang YJ; Zhang XL; Li MH; Iqbal J; Bourantas CV; Li JJ; Su XY; Muramatsu T; Tian NL; Chen SL
J Cardiovasc Pharmacol; 2013 Jul; 62(1):50-7. PubMed ID: 23846802
[TBL] [Abstract][Full Text] [Related]
24. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
25. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
[TBL] [Abstract][Full Text] [Related]
26. Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation.
Koch SE; Mann A; Jones S; Robbins N; Alkhattabi A; Worley MC; Gao X; Lasko-Roiniotis VM; Karani R; Fulford L; Jiang M; Nieman M; Lorenz JN; Rubinstein J
J Hypertens; 2017 Mar; 35(3):602-611. PubMed ID: 28009703
[TBL] [Abstract][Full Text] [Related]
27. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
[TBL] [Abstract][Full Text] [Related]
28.
Lin L; Xu W; Li Y; Zhu P; Yuan W; Liu M; Shi Y; Chen Y; Liang J; Chen J; Yang B; Cai W; Wen Y; Zhu X; Peng X; Zhou Z; Mo X; Wan Y; Yuan H; Li F; Ye X; Jiang Z; Wang Y; Zhuang J; Fan X; Wu X
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1634-H1645. PubMed ID: 33635162
[TBL] [Abstract][Full Text] [Related]
29. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
[TBL] [Abstract][Full Text] [Related]
30. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Jacobshagen C; Grüber M; Teucher N; Schmidt AG; Unsöld BW; Toischer K; Nguyen VP; Maier LS; Kögler H; Hasenfuss G
Eur J Heart Fail; 2008 Apr; 10(4):334-42. PubMed ID: 18343721
[TBL] [Abstract][Full Text] [Related]
32. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and Celecoxib Regulate Notch1/Hes1 Pathway to Prevent Pressure Overload-Induced Myocardial Hypertrophy.
Wei M; Lu Z; Zhang H; Fan X; Zhang X; Jiang B; Li J; Xue M
Int Heart J; 2024; 65(3):475-486. PubMed ID: 38825493
[TBL] [Abstract][Full Text] [Related]
34. Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction.
Qu J; Zhou J; Yi XP; Dong B; Zheng H; Miller LM; Wang X; Schneider MD; Li F
J Mol Cell Cardiol; 2007 Sep; 43(3):319-26. PubMed ID: 17673255
[TBL] [Abstract][Full Text] [Related]
35. Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro.
Meng Y; Zhang Y; Ma Z; Zhou H; Ni J; Liao H; Tang Q
Herz; 2019 May; 44(3):247-256. PubMed ID: 29101624
[TBL] [Abstract][Full Text] [Related]
36. Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/beta-catenin pathway.
Deng L; Hu S; Baydoun AR; Chen J; Chen X; Cong X
Cell Prolif; 2009 Dec; 42(6):721-30. PubMed ID: 19706045
[TBL] [Abstract][Full Text] [Related]
37. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo.
Boluyt MO; Li ZB; Loyd AM; Scalia AF; Cirrincione GM; Jackson RR
Cardiovasc Drugs Ther; 2004 Jul; 18(4):257-67. PubMed ID: 15367823
[TBL] [Abstract][Full Text] [Related]
38. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth.
Haq S; Michael A; Andreucci M; Bhattacharya K; Dotto P; Walters B; Woodgett J; Kilter H; Force T
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4610-5. PubMed ID: 12668767
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.
Chen Y; Zeng D; Ding L; Li XL; Liu XT; Li WJ; Wei T; Yan S; Xie JH; Wei L; Zheng QS
BMC Cell Biol; 2015 Sep; 16():22. PubMed ID: 26335746
[TBL] [Abstract][Full Text] [Related]
40. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
